‘It’s a Vote for Hope’: First Gene Therapy for Muscular Dystrophy Nears Approval, but Will It Work?

On 22 June, the US FDA would decide whether to grant a fast-track approval to the first gene therapy for Duchenne muscular dystrophy, a genetic disorder that affects around 1 in 3,500 boys.